COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States,
March–July 2020 | MMWR Skip directly to site content Skip directly to page options Skip directly …

Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of
SARS-CoV-2 infection in children and adolescents. Since June 2020, several case reports …

Multisystem inflammatory syndrome in children (MIS-C) has been observed in temporal
association with coronavirus disease 2019 (COVID-19), typically within 2 to 6 weeks of …

Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …

Children | Free Full-Text | Multi-System Inflammatory Syndrome in Children (MIS-C)
Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical …

INTRODUCTION—A novel coronavirus was identified in late 2019 that rapidly reached
pandemic proportions. The World Health Organization (WHO) has designated the disease …

Background Multisystem inflammatory syndrome in children (MIS-C), also known as
pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that is …

Importance Multiple inflammatory syndrome in children (MIS-C) occurs in association with
the COVID-19 pandemic. Objective To describe the clinical characteristics and geographic …

Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including
more than 285,000 deaths have been reported to WHO. The risk of severe disease and …

Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C)
may inform efforts to improve health outcomes. Objective To compare clinical characteristics …